3D Non-invasive Myocardial Electrical Propagation Mapping as a New Tool to Predict Sudden Death Risk in Patients With Hypertrophic Cardiomyopathy

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

January 28, 2019

Primary Completion Date

September 23, 2022

Study Completion Date

September 23, 2022

Conditions
Hypertrophic Cardiomyopathy
Interventions
DEVICE

CardioInsight™ Noninvasive 3D Mapping System

"The CardioInsight system uses a proprietary, single-use, disposable multi-electrode vest to capture electrical signals from the body surface. The CardioInsight software provides various cardiac signal analyses and displays interactive 3-D color maps including activation, voltage, composite and phase maps. The vest wearing is coupled with a CT scan.~This exam will be performed only at baseline visit."

Trial Locations (1)

Unknown

Hôpital Louis Pradel, Bron

All Listed Sponsors
lead

Hospices Civils de Lyon

OTHER

NCT03550573 - 3D Non-invasive Myocardial Electrical Propagation Mapping as a New Tool to Predict Sudden Death Risk in Patients With Hypertrophic Cardiomyopathy | Biotech Hunter | Biotech Hunter